A localized case-control study of extra-gastric manifestations of Helicobacter pylori infection in children

Rasha Abdel-Raouf Afifi1, Dina Kamal Ali, Iman Abdel-Mohsen Shaheen

  • 1Department of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt. r_abdelraouf@yahoo.com

Insights

Helicobacter pylori infection in children is linked to a higher risk of iron deficiency and iron deficiency anemia. Further research is needed to confirm these findings and study the effects of eradication therapy.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Hematology

Background:

  • Helicobacter pylori (H. pylori) infection is common in children.
  • Extra-gastric manifestations of H. pylori are not fully understood in pediatric populations.
  • Iron deficiency and anemia are significant health concerns in children.

Purpose of the Study:

  • To investigate the association between H. pylori infection and extra-gastric manifestations in Egyptian children.
  • To determine the prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) in H. pylori-positive children compared to H. pylori-negative children.

Main Methods:

  • A case-control study involving 30 H. pylori-positive and 30 H. pylori-negative children.
  • Data collection included medical history, clinical examination, complete blood count (CBC), serum iron, serum ferritin, and H. pylori antibody testing.

Main Results:

  • H. pylori-positive children showed a statistically significant increase in the frequency of ID (p=0.003) and IDA (p=0.000).
  • While mean hemoglobin, MCV, MCH, serum iron, and serum ferritin were lower in seropositive patients, these differences were not statistically significant.
  • No significant differences were observed in platelet counts, skin disorders, or gender between the two groups.

Conclusions:

  • H. pylori infection is associated with an increased incidence of ID and IDA in children.
  • Larger therapeutic randomized controlled trials are recommended to confirm these findings.
  • Further studies should investigate the hematological response to H. pylori eradication therapy.
Abstract

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...